VectivBio Holding AG
|Market Cap (Intraday)||315.21M|
|2yr Forward PE||N/A|
VectivBio Holding AG Stock, NASDAQ:VECT
VectivBio Holding AG is a clinical-stage biotechnology company, which engages in the development of treatments for severe rare conditions with significant unmet medical need. Its product pipeline include Apraglutide and CoMet. The company was founded by Luca Santarelli on May 22, 2019 and is headquartered in Basel, Switzerland.